ArticleAdvanced healthcare materials2025
PLUS: Primary Layer for Universal Sensing Enabling Improved Immunocapture of Biomarkers in Clinical Scenarios.
Article in Advanced healthcare materials, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Enhancing the Versatility of Polyethylene Terephthalate (PET) Through Strategic Biomolecular Functionalization.Angewandte Chemie (International ed. in English) · 2026Review
- PLUS: Primary Layer for Universal Sensing Enabling Improved Immunocapture of Biomarkers in Clinical Scenarios.Advanced healthcare materials · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
The biofunctionalization of sensor surfaces to enable biorecognition capabilities remains a major challenge in developing diagnostic devices. However, efficient surface chemistries applicable to various sensor types remain elusive. In this study, Primary Layer for Universal Sensing (PLUS), a universal coating for bioprobe immobilization designed to enhance sensor functionality across diverse substrates, is introduced. Derived from the mussel-inspired, catechol-based adhesive polydopamine (pDA), PLUS ensures material-independent coating ability. Unlike conventional methods that involve secondary bioprobe immobilization onto a pre-formed pDA layer, PLUS is directly grown from dopamine (DA) and avidin proteins as co-polymerization precursors, resulting in a highly roughened surface with abundant biotin-binding sites. This strategy, combined with end-functionalization using biotinylated antibodies, significantly enhances immunocapture efficiency compared to traditional immunoassays. Furthermore, the PLUS layer interacts effectively with blocking proteins, preventing non-specific binding of unwanted molecules. This ensures reliable biomarker capture even in complex biological samples, such as 50% human serum and plasma. It is envisioned that this bioprobe immobilization technique will play a pivotal role in advancing high-performance sensor adaptability for molecular diagnostics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.